FORIAN INC (FORA)
US34630N1063 - Common Stock
Taking everything into account, FORA scores 4 out of 10 in our fundamental rating. FORA was compared to 40 industry peers in the Health Care Technology industry. FORA has only an average score on both its financial health and profitability. FORA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year FORA was profitable.
FORA had a positive operating cash flow in the past year.
In the past 5 years FORA reported 4 times negative net income.
In the past 5 years FORA reported 4 times negative operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 18.86%, FORA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
FORA has a better Return On Equity (42.43%) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.86% | ||
| ROE | 42.43% | ||
| ROIC | N/A |
ROA(3y)-28%
ROA(5y)-27.33%
ROE(3y)-90.72%
ROE(5y)-66.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of FORA (54.25%) is better than 100.00% of its industry peers.
FORA has a Gross Margin of 73.31%. This is in the better half of the industry: FORA outperforms 74.36% of its industry peers.
In the last couple of years the Gross Margin of FORA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 54.25% | ||
| GM | 73.31% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.12%
GM growth 5Y14.3%
2. Health
2.1 Basic Checks
FORA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FORA has less shares outstanding
Compared to 5 years ago, FORA has less shares outstanding
The debt/assets ratio for FORA has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.50, we must say that FORA is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 1.50, FORA is doing good in the industry, outperforming 61.54% of the companies in the same industry.
The Debt to FCF ratio of FORA is 38.07, which is on the high side as it means it would take FORA, 38.07 years of fcf income to pay off all of its debts.
FORA has a better Debt to FCF ratio (38.07) than 69.23% of its industry peers.
FORA has a Debt/Equity ratio of 0.95. This is a neutral value indicating FORA is somewhat dependend on debt financing.
The Debt to Equity ratio of FORA (0.95) is worse than 74.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.95 | ||
| Debt/FCF | 38.07 | ||
| Altman-Z | 1.5 |
ROIC/WACCN/A
WACC9.71%
2.3 Liquidity
FORA has a Current Ratio of 8.38. This indicates that FORA is financially healthy and has no problem in meeting its short term obligations.
FORA has a Current ratio of 8.38. This is amongst the best in the industry. FORA outperforms 94.87% of its industry peers.
A Quick Ratio of 8.38 indicates that FORA has no problem at all paying its short term obligations.
FORA's Quick ratio of 8.38 is amongst the best of the industry. FORA outperforms 94.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.38 | ||
| Quick Ratio | 8.38 |
3. Growth
3.1 Past
FORA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.41%, which is quite impressive.
Looking at the last year, FORA shows a very negative growth in Revenue. The Revenue has decreased by -18.51% in the last year.
Measured over the past years, FORA shows a quite strong growth in Revenue. The Revenue has been growing by 16.46% on average per year.
EPS 1Y (TTM)107.41%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q136.36%
Revenue 1Y (TTM)-18.51%
Revenue growth 3Y235.99%
Revenue growth 5Y16.46%
Revenue growth Q2Q-32.04%
3.2 Future
Based on estimates for the next years, FORA will show a small growth in Earnings Per Share. The EPS will grow by 5.12% on average per year.
Based on estimates for the next years, FORA will show a quite strong growth in Revenue. The Revenue will grow by 13.64% on average per year.
EPS Next Y-74.5%
EPS Next 2Y5.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.3%
Revenue Next 2Y13.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 45.34, which means the current valuation is very expensive for FORA.
Based on the Price/Earnings ratio, FORA is valued a bit cheaper than the industry average as 74.36% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of FORA to the average of the S&P500 Index (24.92), we can say FORA is valued expensively.
With a Price/Forward Earnings ratio of 177.78, FORA can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, FORA is valued a bit cheaper than the industry average as 71.79% of the companies are valued more expensively.
FORA is valuated expensively when we compare the Price/Forward Earnings ratio to 21.49, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.34 | ||
| Fwd PE | 177.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FORA indicates a somewhat cheap valuation: FORA is cheaper than 66.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 129.61 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.12%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for FORA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FORIAN INC
NASDAQ:FORA (4/26/2024, 3:30:00 PM)
2.7201
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap84.68M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.34 | ||
| Fwd PE | 177.78 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.86% | ||
| ROE | 42.43% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | 54.25% | ||
| GM | 73.31% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.95 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 8.38 | ||
| Quick Ratio | 8.38 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)107.41%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-74.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-18.51%
Revenue growth 3Y235.99%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y